Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Cash (2016 - 2025)

Historic Change in Cash for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$510000.0.

  • Biomerica's Change in Cash fell 1383.93% to -$510000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $172000.0, marking a year-over-year increase of 10361.19%. This contributed to the annual value of -$1.8 million for FY2025, which is 6810.24% up from last year.
  • As of Q4 2025, Biomerica's Change in Cash stood at -$510000.0, which was down 1383.93% from $654000.0 recorded in Q3 2025.
  • Over the past 5 years, Biomerica's Change in Cash peaked at $6.4 million during Q2 2023, and registered a low of -$4.3 million during Q2 2022.
  • For the 5-year period, Biomerica's Change in Cash averaged around -$156923.8, with its median value being -$584000.0 (2025).
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 82336.72% in 2022, then crashed by 119556.96% in 2023.
  • Over the past 5 years, Biomerica's Change in Cash (Quarter) stood at $2.2 million in 2021, then plummeted by 145.77% to -$1.0 million in 2022, then rose by 15.28% to -$854000.0 in 2023, then surged by 47.54% to -$448000.0 in 2024, then decreased by 13.84% to -$510000.0 in 2025.
  • Its Change in Cash was -$510000.0 in Q4 2025, compared to $654000.0 in Q3 2025 and -$658000.0 in Q2 2025.